Letícia Cruz advances nanomaterials for biopharmaceutics, developing and characterizing nanoemulsions, polymeric nanocapsules and hydrogels. Her work spans preclinical efficacy, stability and HPLC analytics to support drug evaluation, repositioning and robust formulations for inflammatory and pain indications.